PRESS RELEASE published on 08/06/2024 at 06:45, 3 months 15 days ago Solide croissance de Galenica dans un contexte de marché complexe Le chiffre d’affaires du Groupe Galenica a augmenté de 2.6% au premier semestre 2024, dépassant le marché. Perspectives confirmées pour 2024 avec une croissance du chiffre d’affaires de 3% à 5% Croissance Perspectives 2024 Galenica AG Résultat Semestriel Marché Complexe
PRESS RELEASE published on 08/06/2024 at 06:45, 3 months 15 days ago Galenica achieves solid growth in a challenging market environment Galenica achieves solid growth in the first half of 2024 with 2.6% sales increase, confirming 2024 guidance. 10.7% EBIT growth seen, with various successes in healthcare services and market expansion Sales Growth Market Expansion Galenica EBIT Increase Healthcare Services
BRIEF published on 07/22/2024 at 18:16, 3 months 29 days ago Galenica Increases Stake in Redcare Pharmacy to 10% Investment Shareholding Redcare Pharmacy Galenica Pharmacy
BRIEF published on 07/22/2024 at 18:16, 3 months 29 days ago Galenica augmente sa participation dans Redcare Pharmacy à 10% Investissement Actionnariat Galénique Pharmacie Redcare Pharmacie
PRESS RELEASE published on 07/22/2024 at 18:11, 3 months 29 days ago Galenica increases shareholding in Redcare Pharmacy to 10% Galenica increases stake in Redcare Pharmacy to 10% as part of strategic partnership, aiming for long-term investment benefits Strategic Partnership Investment Redcare Pharmacy Online Pharmacy Galenica
PRESS RELEASE published on 07/22/2024 at 18:11, 3 months 29 days ago Galenica augmente à 10% sa participation dans Redcare Pharmacy Galenica augmente sa participation dans Redcare Pharmacy à 10% renforçant ainsi leur partenariat stratégique Investissement Participation Redcare Pharmacy Pharmacie En Ligne Galenica AG
BRIEF published on 05/23/2024 at 06:50, 5 months 29 days ago Galenica stays the course with sales growth Pharmaceutical Growth Turnover Galenica Generics
BRIEF published on 05/23/2024 at 06:50, 5 months 29 days ago Galenica maintient le cap avec une croissance du chiffre d’affaires Croissance Chiffre D’affaires Galenica Pharmaceutique Génériques
PRESS RELEASE published on 05/23/2024 at 06:45, 5 months 29 days ago Galenica on track with sales growth Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5% Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
PRESS RELEASE published on 05/23/2024 at 06:45, 5 months 29 days ago Galenica maintient le cap avec une croissance du chiffre d’affaires Galenica maintient sa croissance avec une hausse de 4.8% de son chiffre d'affaires pour les quatre premiers mois de 2024. Perspectives confirmées pour 2024 Chiffre D'affaires Croissance Résultat De Ventes Perspectives 2024 Galenica AG
Published on 11/21/2024 at 16:30, 27 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 56 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 57 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 57 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 15:41, 1 hour 15 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 9 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 59 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 20 hours 49 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
